838 related articles for article (PubMed ID: 15557178)
1. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
2. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
Avril T; Freeman SD; Attrill H; Clarke RG; Crocker PR
J Biol Chem; 2005 May; 280(20):19843-51. PubMed ID: 15769739
[TBL] [Abstract][Full Text] [Related]
3. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
5. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
[TBL] [Abstract][Full Text] [Related]
7. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
8. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2.
Taylor VC; Buckley CD; Douglas M; Cody AJ; Simmons DL; Freeman SD
J Biol Chem; 1999 Apr; 274(17):11505-12. PubMed ID: 10206955
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2.
Ulyanova T; Shah DD; Thomas ML
J Biol Chem; 2001 Apr; 276(17):14451-8. PubMed ID: 11278955
[TBL] [Abstract][Full Text] [Related]
10. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
11. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor.
Ulyanova T; Blasioli J; Woodford-Thomas TA; Thomas ML
Eur J Immunol; 1999 Nov; 29(11):3440-9. PubMed ID: 10556798
[TBL] [Abstract][Full Text] [Related]
12. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
13. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.
Paul SP; Taylor LS; Stansbury EK; McVicar DW
Blood; 2000 Jul; 96(2):483-90. PubMed ID: 10887109
[TBL] [Abstract][Full Text] [Related]
14. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
Yusa S; Campbell KS
J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor.
Bellón T; Kitzig F; Sayós J; López-Botet M
J Immunol; 2002 Apr; 168(7):3351-9. PubMed ID: 11907092
[TBL] [Abstract][Full Text] [Related]
16. Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal.
Kabat J; Borrego F; Brooks A; Coligan JE
J Immunol; 2002 Aug; 169(4):1948-58. PubMed ID: 12165520
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of leucocyte functions by CD33-related siglecs.
Avril T; Attrill H; Zhang J; Raper A; Crocker PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
[TBL] [Abstract][Full Text] [Related]
19. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization.
Lu-Kuo JM; Joyal DM; Austen KF; Katz HR
J Biol Chem; 1999 Feb; 274(9):5791-6. PubMed ID: 10026201
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of S2V, a novel putative siglec that contains two V set Ig-like domains and recruits protein-tyrosine phosphatases SHPs.
Yu Z; Lai CM; Maoui M; Banville D; Shen SH
J Biol Chem; 2001 Jun; 276(26):23816-24. PubMed ID: 11328818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
